CRT 2026
Innovation and Technology
Marek Grygier, MD, PhD, FESC
Director of Catheterization Laboratory and Head of Structural Heart Interventions Program
Poznan University of Medical Sciences
Disclosure(s): 4C medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merillife Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)